Reprieve Cardiovascular Email Format
Medical Equipment ManufacturingMassachusetts, United States11-50 Employees
Reprieve Cardiovascular, Inc. is a medical device company focused on improving fluid management for patients with acute decompensated heart failure. Its work centers on decongestion therapy intended to safely accelerate fluid removal, with the aim of addressing the needs of heart failure patients who require improved management of congestion. Based in Milford, Massachusetts, the company operates within the medical equipment manufacturing sector and pursues clinical development through studies such as the FASTR Trial, which compares its decongestion management system to standard diuretic therapy in acute cases. Reprieve positions itself as a clinical-stage organization developing intelligent approaches to decongestion, targeting the treatment of a broad heart failure patient population globally.